CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 99 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $132,000 | +153.8% | 22,751 | +68.0% | 0.00% | – |
| Q2 2020 | $52,000 | +20.9% | 13,542 | +22.6% | 0.00% | – |
| Q1 2020 | $43,000 | +2.4% | 11,042 | +1.2% | 0.00% | – |
| Q4 2019 | $42,000 | -27.6% | 10,911 | -18.0% | 0.00% | – |
| Q3 2019 | $58,000 | +23.4% | 13,311 | +7.3% | 0.00% | – |
| Q3 2018 | $47,000 | +23.7% | 12,411 | 0.0% | 0.00% | – |
| Q2 2018 | $38,000 | +35.7% | 12,411 | +8.8% | 0.00% | – |
| Q1 2018 | $28,000 | -31.7% | 11,411 | +9.6% | 0.00% | – |
| Q4 2017 | $41,000 | – | 10,411 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |